V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211456 | 20174552 | null | 80.3 | null | 2018-06-11 | 2018-06-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101755339 |
| 20211465 | 20174553 | 1.74 | null | Palliative (P) | 2019-08-31 | 2019-08-31 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101491430 |
| 20211488 | 20174555 | 1.7 | 76.9 | Adjuvant (A) | 2020-05-10 | 2020-05-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101119237 |
| 20211490 | 20174556 | 1.68 | 66.3 | null | 2021-07-05 | 2021-08-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100866943 |
| 20211532 | 20174557 | 1.85 | 58 | Palliative (P) | 2018-01-18 | 2018-01-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100187634 |
| 20211552 | 20174558 | 1.74 | 73.9 | Palliative (P) | 2018-01-21 | 2018-01-24 | Docetaxel | 02 | N | DOCETAXEL | 100342809 |
| 20211560 | 20174559 | 0 | 92.4 | Palliative (P) | 2019-06-28 | 2019-08-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101062134 |
| 20211571 | 20174560 | 1.7 | 49.9 | Palliative (P) | 2020-02-04 | 2020-02-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101839357 |
| 20211573 | 20174561 | 1.53 | 65.8 | Palliative (P) | 2019-10-23 | 2019-12-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100614483 |
| 20211583 | 20174562 | 1.94 | 69.2 | null | 2018-09-01 | 2018-09-15 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101045102 |
| 20211598 | 20174563 | 1.68 | 61.1 | null | 2017-07-08 | 2017-07-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101211617 |
| 20211626 | 20174564 | 1.74 | 62 | Palliative (P) | 2017-08-09 | 2017-08-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101565646 |
| 20211662 | 20174566 | 1.76 | 61 | null | 2019-07-01 | 2019-10-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100934687 |
| 20211675 | 20174567 | 1.88 | 74.3 | null | 2020-05-24 | 2020-07-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 101557749 |
| 20211688 | 20174568 | 1.87 | 61 | Palliative (P) | 2021-07-13 | 2021-07-13 | Docetaxel | 02 | N | DOCETAXEL | 100187592 |
| 20211694 | 20174569 | 1.7 | 72.6 | Palliative (P) | 2018-10-02 | 2018-10-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100790072 |
| 20211695 | 20174570 | 1.54 | 89.5 | Palliative (P) | 2016-06-01 | 2016-06-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101692068 |
| 20211742 | 20174571 | 1.63 | 101 | Palliative (P) | 2020-07-31 | 2020-09-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101302799 |
| 20211768 | 20174572 | 1.73 | 75.6 | null | 2021-10-03 | 2022-01-26 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101404871 |
| 20211779 | 20174573 | 1.7 | 61 | Palliative (P) | 2019-12-07 | 2019-12-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101149212 |
| 20211785 | 20174574 | 1.65 | 81.6 | Palliative (P) | 2018-06-23 | 2018-07-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100153353 |
| 20211793 | 20174575 | 1.66 | 71 | Palliative (P) | 2018-08-08 | 2018-08-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100095164 |
| 20211809 | 20174576 | 2 | 80.2 | null | 2019-12-01 | 2019-12-17 | Gemcitabine + Capecitabine | 02 | null | DOCETAXEL | 100624907 |
| 20211870 | 20174577 | 1.73 | 82.1 | Palliative (P) | 2021-11-19 | 2021-11-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100018303 |
| 20211880 | 20174578 | null | 55 | Palliative (P) | 2019-12-13 | 2019-12-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100223552 |
| 20211921 | 20174579 | 1.69 | 63.6 | Palliative (P) | 2018-08-13 | 2018-08-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100758038 |
| 20211938 | 20174580 | 1.76 | 54.6 | Palliative (P) | null | null | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101044780 |
| 20211960 | 20174581 | 1.76 | 69 | Palliative (P) | 2020-08-26 | 2020-10-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101749462 |
| 20212029 | 20174582 | 1.67 | 95 | null | 2022-04-02 | 2022-05-26 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100617706 |
| 20212054 | 20174583 | 1.52 | 79.6 | Palliative (P) | 2020-08-09 | 2020-08-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100945805 |
| 20212059 | 20174584 | 1.74 | 61.9 | null | 2020-02-07 | 2021-09-27 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100101009 |
| 20212060 | 20174585 | 1.7 | 71.3 | Palliative (P) | 2021-07-14 | 2021-07-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101315481 |
| 20212064 | 20174586 | 1.67 | 89.2 | Adjuvant (A) | 2019-08-09 | 2019-08-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101324258 |
| 20212067 | 20174587 | 1.51 | 83.2 | Palliative (P) | 2016-04-07 | 2016-08-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101124124 |
| 20212070 | 20174588 | 1.59 | 58.95 | Palliative (P) | 2018-03-13 | 2018-03-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101820944 |
| 20212072 | 20174589 | 1.59 | 51.8 | Palliative (P) | null | 2018-11-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100836957 |
| 20212080 | 20174590 | 1.7 | 79.1 | null | 2022-01-24 | 2022-03-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100503967 |
| 20212082 | 20174591 | 1.74 | 66.3 | Palliative (P) | 2020-07-04 | 2020-07-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100467371 |
| 20212106 | 20174593 | 1.74 | 80 | Palliative (P) | 2019-05-10 | 2019-05-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100604540 |
| 20212108 | 20174594 | 1.93 | 67.4 | Palliative (P) | 2019-02-03 | 2019-02-24 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100352970 |
| 20212116 | 20174595 | null | 81 | null | 2017-07-12 | 2017-08-02 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100627340 |
| 20212124 | 20174596 | 1.91 | 61 | Palliative (P) | 2022-02-07 | 2022-02-07 | Docetaxel | 02 | N | DOCETAXEL | 101574246 |
| 20212126 | 20174597 | 1.62 | 89.2 | Palliative (P) | 2021-08-10 | 2022-02-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101386554 |
| 20212127 | 20174598 | 1.61 | 53 | null | 2017-02-19 | 2017-11-27 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100531517 |
| 20212128 | 20174599 | 0 | 77.2 | Palliative (P) | 2020-06-24 | 2020-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101798688 |
| 20212129 | 20174600 | 1.6 | 88 | Palliative (P) | 2018-09-13 | 2018-09-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100195871 |
| 20212135 | 20174601 | 1.6 | 61.5 | Palliative (P) | 2021-07-18 | 2021-07-30 | Docetaxel | 02 | N | DOCETAXEL | 100936534 |
| 20212143 | 20174602 | 1.86 | 79 | null | 2019-04-06 | 2019-04-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100875807 |
| 20212144 | 20174603 | 1.69 | 67 | Palliative (P) | 2021-07-07 | 2021-07-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100674751 |
| 20212148 | 20174604 | 1.77 | 58 | null | 2019-04-29 | 2019-05-22 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 101389036 |